Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rafutrombopag by Jiangsu Hengrui Medicine for Thrombocytopenia: Likelihood of Approval
Rafutrombopag is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Thrombocytopenia. According to GlobalData, Phase...